These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 24076580)
1. Recent advances in the management of mantle cell lymphoma. Rivera-Rodriguez N; Cabanillas F Curr Opin Oncol; 2013 Nov; 25(6):716-21. PubMed ID: 24076580 [TBL] [Abstract][Full Text] [Related]
2. The emerging role of lenalidomide in the management of mantle cell lymphoma (MCL). Dawar R; Hernandez-Ilizaliturri F Best Pract Res Clin Haematol; 2012 Jun; 25(2):185-90. PubMed ID: 22687454 [TBL] [Abstract][Full Text] [Related]
3. Mantle cell lymphoma: the promise of new treatment options. Goy A; Kahl B Crit Rev Oncol Hematol; 2011 Oct; 80(1):69-86. PubMed ID: 21168343 [TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphoma. Hess G; Keller U; Scholz CW; Witzens-Harig M; Atta J; Buske C; Kirschey S; Ruckes C; Medler C; van Oordt C; Klapper W; Theobald M; Dreyling M Leukemia; 2015 Aug; 29(8):1695-701. PubMed ID: 25765545 [TBL] [Abstract][Full Text] [Related]
5. Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation. Visco C; Finotto S; Zambello R; Paolini R; Menin A; Zanotti R; Zaja F; Semenzato G; Pizzolo G; D'Amore ES; Rodeghiero F J Clin Oncol; 2013 Apr; 31(11):1442-9. PubMed ID: 23401442 [TBL] [Abstract][Full Text] [Related]
6. Autologous transplantation and management of younger patients with mantle cell lymphoma. Geisler CH Best Pract Res Clin Haematol; 2012 Jun; 25(2):211-20. PubMed ID: 22687457 [TBL] [Abstract][Full Text] [Related]
14. Management of mantle cell lymphoma: key challenges and next steps. Williams ME; Dreyling M; Winter J; Muneer S; Leonard JP Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):336-46. PubMed ID: 21030346 [TBL] [Abstract][Full Text] [Related]
15. Treatment of older patients with mantle-cell lymphoma. Kluin-Nelemans HC; Hoster E; Hermine O; Walewski J; Trneny M; Geisler CH; Stilgenbauer S; Thieblemont C; Vehling-Kaiser U; Doorduijn JK; Coiffier B; Forstpointner R; Tilly H; Kanz L; Feugier P; Szymczyk M; Hallek M; Kremers S; Lepeu G; Sanhes L; Zijlstra JM; Bouabdallah R; Lugtenburg PJ; Macro M; Pfreundschuh M; Procházka V; Di Raimondo F; Ribrag V; Uppenkamp M; André M; Klapper W; Hiddemann W; Unterhalt M; Dreyling MH N Engl J Med; 2012 Aug; 367(6):520-31. PubMed ID: 22873532 [TBL] [Abstract][Full Text] [Related]
16. Bortezomib, bendamustine, and rituximab in patients with relapsed or refractory follicular lymphoma: the phase II VERTICAL study. Fowler N; Kahl BS; Lee P; Matous JV; Cashen AF; Jacobs SA; Letzer J; Amin B; Williams ME; Smith S; Saleh A; Rosen P; Shi H; Parasuraman S; Cheson BD J Clin Oncol; 2011 Sep; 29(25):3389-95. PubMed ID: 21810687 [TBL] [Abstract][Full Text] [Related]
17. Recent advances in the treatment of mantle cell lymphoma: a post-ASH 2009 discussion. Czuczman MS; Leonard JP; Williams ME Clin Adv Hematol Oncol; 2010 Apr; 8(4):A1-14; quiz A15. PubMed ID: 20552750 [TBL] [Abstract][Full Text] [Related]
18. Combination biologic therapy without chemotherapy as initial treatment for mantle cell lymphoma: multi- center phase II study of lenalidomide plus rituximab. Clin Adv Hematol Oncol; 2014 Feb; 12(2 Suppl 6):17-8. PubMed ID: 24870878 [No Abstract] [Full Text] [Related]